Other Vaccines - Lesotho

Lesotho

Highlights

The Other Vaccines market in Lesotho is estimated to achieve a revenue of US$982.40k in 2024.
It is anticipated that the market will experience an annual growth rate (CAGR 2024-2029) of 10.61%, leading to a market volume of US$1.63m by 2029.
When compared globally, United States is expected to generate the highest revenue, amounting to US$24.73bn in 2024.
Despite efforts to improve vaccination rates, Lesotho still faces challenges in providing access to other vaccines for its population.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The global vaccine market has been growing steadily over the years, and Lesotho is no exception. Other vaccines market in Lesotho has been developing at a moderate pace in recent years.

Customer preferences: Lesotho has a high demand for vaccines, especially for children. The government of Lesotho has made significant efforts to improve the country's immunization coverage rates, which has led to an increase in the demand for vaccines. Parents in Lesotho are also becoming more aware of the importance of vaccines, which has contributed to the growth of the other vaccines market.

Trends in the market: The other vaccines market in Lesotho has been growing in recent years, primarily due to the increasing demand for vaccines. The government of Lesotho has been investing in its healthcare system, which has led to an increase in the number of healthcare facilities and medical professionals in the country. This, in turn, has led to an increase in the availability of vaccines, which has contributed to the growth of the other vaccines market.

Local special circumstances: Lesotho is a landlocked country with a population of approximately 2.2 million people. The country has a high prevalence of infectious diseases, which has led to an increased demand for vaccines. The government of Lesotho has made significant efforts to improve the country's healthcare system, which has contributed to the growth of the other vaccines market. However, the country faces challenges such as a lack of adequate healthcare infrastructure, shortage of medical professionals, and limited financial resources.

Underlying macroeconomic factors: Lesotho is one of the poorest countries in the world, with a GDP per capita of approximately $1,200. The country heavily relies on foreign aid to support its economy. The government of Lesotho has been investing in its healthcare system, but the country's limited financial resources pose a challenge to the growth of the other vaccines market. However, the government of Lesotho has made significant efforts to improve the country's healthcare system, which has contributed to the growth of the other vaccines market.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.